QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng 收藏  |  浏览/下载：42/0  |  提交时间：2021/05/24 vicagrel  [C-14]vicagrel  vicagrel pharmacokinetics  vicagrel metabolism  mass balance  P2Y(12) receptor inhibitor   Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127, 页码: 151-160 作者:  Li, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei 收藏  |  浏览/下载：102/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  P2Y(12) inhibitor  Pharmacokinetics  Active metabolite  Thienopyridine   Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127 作者:  Liu, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei 收藏  |  浏览/下载：26/0  |  提交时间：2019/12/05 Vicagrel  Clopidogrel  P2Y(12) inhibitor  Pharmacokinetics  Active metabolite  Thienopyridine   Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers 期刊论文 FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9 作者:  Li, Xiaojiao;  Liu, Ca;  Zhu, Xiaoxue;  Wei, Haijing;  Zhang, Hong 收藏  |  浏览/下载：56/0  |  提交时间：2019/01/08 vicagrel  pharmacokinetics  pharmacodynamics  safety  clopidogrel   Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 卷号: 149, 页码: 394-402 作者:  Liu, Cai;  Lu, Youming;  Sun, Hongbin;  Yang, Jin;  Liu, Yongqiang 收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  Active metabolite  LC-MS/MS  Human plasma  P2Y(12) inhibitor   Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers 期刊论文 FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9 作者:  Li, Xiaojiao;  Liu, Ca;  Zhu, Xiaoxue;  Wei, Haijing;  Zhang, Hong 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05 vicagrel  pharmacokinetics  pharmacodynamics  safety  clopidogrel   Arylacetamide Deacetylase Is Involved in Vicagrel Bioactivation in Humans 期刊论文 FRONTIERS IN PHARMACOLOGY, 2017, 卷号: 8 作者:  Jiang, Jinfang;  Chen, Xiaoyan;  Zhong, Dafang 收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08 arylacetamide deacetylase  vicagrel  clopidogrel  hydrolytic metabolism   METABOLISM AND PHARMACOKINETICS OF VICAGREL, A NOVEL THIENOPYRIDINE P2Y12 INHIBITOR, COMPARED WITH CLOPIDOGREL IN HEALTHY CHINESE SUBJECTS 会议论文 作者:  Liu, Cai;  Chen, Xiaoyan;  Zhong, Dafang 收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08